GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eviana Health Corp (XCNQ:EHC) » Definitions » Debt-to-Revenue

Eviana Health (XCNQ:EHC) Debt-to-Revenue : N/A (As of Mar. 2019)


View and export this data going back to 2017. Start your Free Trial

What is Eviana Health Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Eviana Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2019 was C$0.02 Mil. Eviana Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2019 was C$8.02 Mil. Eviana Health's annualized Revenue for the quarter that ended in Mar. 2019 was C$0.00 Mil.


Eviana Health Debt-to-Revenue Historical Data

The historical data trend for Eviana Health's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eviana Health Debt-to-Revenue Chart

Eviana Health Annual Data
Trend Jun15 Jun16 Jun17 Jun18
Debt-to-Revenue
N/A N/A N/A N/A

Eviana Health Quarterly Data
Jun15 Mar16 Jun16 Sep16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A N/A N/A N/A

Competitive Comparison of Eviana Health's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Eviana Health's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eviana Health's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eviana Health's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Eviana Health's Debt-to-Revenue falls into.



Eviana Health Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Eviana Health's Debt-to-Revenue for the fiscal year that ended in Jun. 2018 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.023 + 0.016) / N/A
=N/A

Eviana Health's annualized Debt-to-Revenue for the quarter that ended in Mar. 2019 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.017 + 8.019) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2019) Revenue data.


Eviana Health Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Eviana Health's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Eviana Health (XCNQ:EHC) Business Description

Traded in Other Exchanges
N/A
Address
5728 East Boulevard, Vancouver, BC, CAN, V6M 4M4
Eviana Health Corp produces and sells cannabinoid products from natural hemp strains of cannabis sativa for consumer health-care products, pharmaceuticals, nutraceuticals, and cosmeceuticals, as well as for topical creams and other health and wellness products.